Human placenta is a highly perspective source of multipotent stromal cells (MSCs) both for the purposes of patient specific auto-banking and allogeneic application in regenerative medicine. Implementation of new GMP standards into clinical practice enforces the search for relevant methods of cryopreservation and short-term hypothermic storage of placental MSCs. In this paper we analyze the effect of different temperature regimes and individual components of cryoprotective media on viability, metabolic and culture properties of placental MSCs. We demonstrate (I) the possibility of short-term hypothermic storage of these cells; (II) determine DMSO and propanediol as the most appropriate cryoprotective agents; (III) show the possibility of application of volume expanders (plasma substituting solutions based on dextran or polyvinylpyrrolidone); (IV) reveal the priority of ionic composition over the serum content in cryopreservation media; (V) determine a cooling rate of 1°C/min down to -40°C followed by immersion into liquid nitrogen as the optimal cryopreservation regime for this type of cells. This study demonstrates perspectives for creation of new defined cryopreservation methods towards GMP standards.
Introduction
Rapid development of regenerative medicine and cell therapy stimulates high demand for multipotent stromal cells (MSCs), due to their proven efficiency in the treatment of numerous severe pathologies of the nervous, cardiovascular, reproductive, and endocrine systems; furthermore skin lesions and venous ulcers [1, 2, 3] .
Although to date different tissues and organs serve as the source of MSCs [3, 4] , the most promising sources are various structural components of placenta including placental villi, fetal lower the temperature at such rate due to the slow cooling properties of isopropyl alcohol. This also permits elimination of necessity for programmable freezers. Further liquid nitrogen based low temperature storage at -196°C is to be preferred due to standardization and simplicity of the process. However, refrigeration equipment with the end temperature of −40°C −80°C became widely available in recent years not only in the research laboratories, but in clinics and blood donation centers as well. Moreover, in accordance with the recommendations of the World Health Organization, certain blood components should be stored at a temperature of less than -40°C (WHO Recommendations for the Production, Control and Regulation of Human Plasma for Fractionation. ECBS 2005. WHO/BS/05.2019). The legislation of Ukraine, for example, also determines the temperature of storage of certain blood components at -30°C --80°C (Order of the Ministry of Health of Ukraine of 17.12.2013 № 1093). Thus, it is necessary to study cryosensitivity of placental MSCs and other therapeutically important stem cell types in this temperature range and analyze necessity and possibilities for modification of existing cryopreservation protocols.
Therefore, in this paper we aim to analyze the influence of various factors of cryopreservation and hypothermic storage on survival and functional parameters of multipotent stromal cells of placental origin.
Materials and Methods

Experimental design
In summary, placental amnion cells were isolated by a standard enzymatic method, characterized for MSC origin as described before [25] , and followed by comprehensive comparative analysis of cells in regular culture conditions with the cells after hypothermic storage at +4°C, subnormothermic storage at +20°C, after cryopreservation with varied composition of cryoprotective medium, different temperature and cooling rate regimens and after repeated freezing.
Cell derivation, isolation, and culture Cell derivation and isolation. Primary culture of MSCs was obtained from placental amnion by enzymatic method [25] . Amnion membranes were washed with PBS with 10% Ciprofloxacin (Fresenius Kabi, Bad Homburg, Germany), then dissected into small pieces and incubated in presence of 0.25% trypsin for 1 hour at 37°C. Following trypsin digestion, samples were filtered through 100 μm cell strainer (BD Biosciences, Durhan, USA), the cell suspension was centrifuged for 5 min at 1200 rpm (Heraeus Multifuge 1S-R, Thermo Fisher Scientific GmbH, Dreieich, Germany), the cell pellet was resuspended in MSC growth medium and plated into 10 cm cell dishes (Cellstar, Greiner BioOne, Frickenhausen, Germany).
Cell culture. MSCs derived from placenta were cultured under sterile conditions in Dulbecco's modified Eagle's medium (DMEM, Biochrom AG, Berlin, Germany) containing 10% (v/v) fetal bovine serum (FBS, Lonza, Belgium), 1% antibiotic-antimycotic solution (BioWest, Nuaillé, France), and 1% ascorbic acid (Sigma-Aldrich, St. Louis, USA) in 10 cm tissue culture dishes (Cellstar, Greiner BioOne, Frickenhausen, Germany) in a humidified CO 2 incubator (Thermo Fisher Scientific GmbH, Dreieich, Germany) at 5% CO 2 and 37°C. The cells were harvested using 0.25% trypsin solution.
Multipotent stromal cells characterization
Reverse transcription polymerase chain reaction (RT-PCR) for MSC markers. RNA extraction was performed with application of peqGOLD Total RNA Kit (Peqlab GmbH, Erlangen, Germany) according to manufacturer's protocol. In brief, the cell pellet was lysed in 400 μl RNA lysis buffer and transferred to a DNA removing column to remove contaminant DNA. After centrifugation at 12,000 x g for 1 min, 400 μl of 70% ethanol was added to the flow through. The lysate was loaded onto a Perfect Bind RNA Column and centrifuged at 10,000 x g for 1 min to bind the RNA to the column,followed by a washing step with 500 μl RNA Wash Buffer I and two times washing with 600 μl RNA Wash Buffer II. The column was dried by centrifugation at 10,000 x g for 2 min and total RNA was eluted from the column by applying 50 μl sterile RNase-free water. The RNA concentration was measured with a NanoDrop photometer ND-1000 (Thermo Fisher Scientific GmbH, Dreieich, Germany). Extracted RNA was transcribed into complementary DNA (cDNA) using the High Capacity cDNA Reverse Transcription Kit (Life Technologies GmbH, Darmstadt, Germany). Adding Oligo (dT) primers (TIB Molbiol, Berlin, Germany) ensured that only the mRNA is transcribed. For analysis of mesenchymal markers a reverse transcription PCR reaction was set up in 30 μl volume per sample as follows: 24 μl ddH 2 O (double distilled water), 3 μl 10x PCR buffer (NEB, Frankfurt, Germany), 0.5 Units Taq Polymerase (NEB, Frankfurt, Germany), 100 mM dNTPs (Fermentas, St. Leon-Rot, Germany), 20 pmol/μl of each primer, and 1 μg cDNA. Thermal cycling conditions included: pre-cycling step at 95°C for 3 min; 35 cycles of denaturation at 95°C for 45 sec; annealing at 60°C for 45 sec; and extension at 72°C for 90 sec with a final extension step at 72°C for 10 min. All oligonucleotides were designed with an annealing temperature of 60°C. A summary of oligonucleotide sequences, fragment sizes and accession numbers is enlisted in S1 Table. Flow cytometry analysis for MSC markers. Cells were removed from culture dishes, aliquoted equally into fluorescence-activated cell sorting (FACS) tubes (Corning, New York, USA) and stained with corresponding antibodies. Cells incubated with secondary antibody were used as controls. Cells were incubated at room temperature with primary and secondary antibody for 1 hour respectively. After each step, cells were washed twice with PBS and then analyzed with a FACSCalibur™ (Becton Dickinson GmbH, Heidelberg, Germany) flow cytometer with a rate of 10,000 events per measurement. Information on primary and secondary antibodies used for flow cytometry experiments is presented in S2 
Hypothermic storage of cells
For hypothermic storage, the cell suspension was adjusted to a concentration of 2x10 5 cells/ml in a culture medium, corresponding to the ratio of the number of cells to the volume of culture medium during cell culturing. Cells were preserved in 10 ml polystyrol tubes with non-adhesive surface (SPL Life Science, Pocheon-Si, South Korea). One portion of the samples was stored at a temperature range from +18°C to +24°C (subnormothermic temperature, which can be considered hypothermic for the cells in comparison to physiological human body temperature), with further evaluation of viability and functional state after 24, 48, 72, and 96 hours. The other portion was stored at +4°C (hypothermic storage), with further evaluation of viability and functional state after 24, 48, 72, and 96 hours. Cells which were directly removed from the culture dish were used as positive controls; cells incubated in 96% ethanol at -20°C were used as negative controls.
the programmable freezer "ЗП-10" ("BioCold" Special Designing and Technical Bureau, Kharkiv, Ukraine) with a cooling rate of 1°C/min down to -70°C, followed by immersion into liquid nitrogen. Afterwards, samples were stored for 7 days at low-temperature storage tank HB-0.5 (JSC "Ural Compressor Plant", Ekaterinburg, Russia). After low temperature storage the samples were thawed in the water bath at +37°C. Cryopreservartion medium was composed of cell culture medium containing 10% FBS supplemented with various conventional CPAs in different concentrations: 5% DMSO (SigmaAldrich, St. Louis, USA), 10% DMSO, 15% DMSO, 11.4% 1,3-Propanediol (Sigma-Aldrich, St. Louis, USA), 6.8% sucrose (Sigma-Aldrich, St. Louis, USA), 9.3% ethylene glycol (SigmaAldrich, St. Louis, USA), 13.8% glycerol (Carl Roth GmbH, Karlsruhe, Germany), 6% HES (Sigma-Aldrich, St. Louis, USA). For selection of a cryoprotective medium with minimal content of substances not authorized in medical practice, the culture medium was replaced with Hank's solution, Ringer's solution, or 0.9% solution of sodium chloride, all supplemented with 10% DMSO as a CPA. Besides, plasma volume expanders, with main components possessing cryoprotective properties according to the literature [26] , were tested as cryopreservation media. These included: 6% dextran (RescueFlow 1 , Pharmanovia, Gentofte, Denmark), sorbitol 6% (Rheosorbilact 1 , YURiA-PHARM Ltd., Kyiv, Ukraine), polyvinylpyrrolidone 6% (Neohemodes 1 , Nicofarm, Kyiv, Ukraine), and 6% hydroxyethyl starch (Refortan 1 Berlin-Chemie AG, Germany). All tested plasma volume expanding solutions are approved for clinical intravenous administration with doses up to 200-1000 ml, thus, further washing procedures after cryopreservation were not required. Additionally, cryoprotective medium composed of culture medium, containing 10% DMSO, but without FBS, was tested. Non-cryopreserved cells were used as positive controls and cells frozen in culture medium without CPA were used as negative controls.
Analysis of influence of cooling rates. Analysis of the influence of cooling rates was performed with cell suspensions in standard culture medium containing 10% FBS and supplemented with 10% DMSO as a CPA. The samples were cooled in the programmable freezer "ЗП-10" at a cooling rate of 1°C/min to end temperatures -20°C, -30°C, -40°C, -50°C, -60°C, and -70°C, with subsequent immersion into liquid nitrogen, storage for 7 days, followed by thawing in a water bath. Non-cryopreserved cells were used as positive controls and cells cryopreserved with the same cryoprotective medium, but directly immersed into liquid nitrogen were used as negative controls.
Additionally, survival of the cells that have been thawed and re-frozen in the same media without washing and passaging was analyzed.
Evaluation of cell number, viability and functional activity of cells
The number of cells was counted in a Neubauer hemacytometer (Marienfeld-Superior, LaudaKönigshofen, Germany) by methylene blue staining. Cell viability was determined by staining with 0.4% Trypan blue as well as with flow cytometry method, measured with a FACSCalibur™ flow cytometer using 7AAD (Becton Dickinson, Franklin Lakes, USA) according to the manufacturer's protocol. Data processing of cytofluorimetric analysis was carried out with "Flowing Software" V. 2.1 program.
Adhesive properties were studied by passaging 2x10 5 cells per well on a 6-well plate, and culturing in a humidified CO 2 incubator (Thermo Fisher Scientific GmbH, Dreieich, Germany) at 5% CO 2 and 37°C. On the following day non-adhered cells were washed off and remaining adhered cells were detached with 0.25% trypsin solution and counted. Cultural properties were studied by passaging 2x10 5 cells per well on a 6-well plate, and culturing in a humidified CO 2 incubator at 5% CO 2 and 37°C until monolayer formation. 
Data analysis and statistics
All data was collected in triplicates from 3 to 5 independent experiments (n3). Mean values and standard deviation calculations (mean±SD) with the following analysis with Mann-Whitney criteria and Fisher's method were used to obtain statistically significant conclusions. The changes of parameters were considered statistically significant at p<0.05. Statgraphics V 2.1 software was utilized for statistical calculations and data analysis.
Results and Discussion
Characterization of the MSCs
Primary cells were adherent to plastic, displayed typical spindle-shaped fibroblast-like morphology in cell culture conditions and were capable to form a monolayer. RT-PCR analysis revealed that cells were positive for typical MSC markers, such as CD90, CD73, and CD105 and negative for hematopoietic marker CD34 (Fig 1A and 1B) . These results were also confirmed on protein level by flow cytometry analysis for CD73 and CD105 markers (Fig 1C and  1D) . Besides, the cells were capable of differentiating into adipogenic, chondrogenic, and osteogenic mesenchymal lineages (Fig 2) . Listed features are considered sufficient for characterizing a cell line as MSC [25, 27] .
Hypothermic and subnormothermic temperature storage
The cell suspension formed aggregates of up to 50-200 μm (Fig 3a) with a minor percentage of single cells when kept at +20°C overnight. There was an average 10% decrease of counted cells (1.8-2x10 5 cells/ml, Table 1 ) with a decrease of viability down to 82.9±5.5% when monitored by Trypan blue staining. Monolayer was formed on the 2nd day (Fig 3b) . After 48 hours of subnormothermic storage a slight decrease in cell number, viability and adhesive properties was observed, but cell conglomerates remained of the same size and number as before; a monolayer formed on day 3-4. After 72-hour storage the cell concentration dropped down to 1.5x10 5 cells/ml, viability decreased to 69.3±5.4% and the monolayer was formed on the 4th day. Further storage of cell suspension under these conditions led to drastic decrease in viability and incapability of monolayer formation.
Analysis of cellular characteristics after hypothermic storage at +4°C in the culture medium without additional components for 24 hours revealed significant decrease of the cell number (Table 1) , which corresponds with the literature [28, 29] . Interestingly, all cells were distinctly located without forming conglomerates (Fig 3c) and adhered instead with poor distribution on the dish, slow proliferation and late monolayer formation on day 8 (Fig 3d) . Hypothermic storage of cells for more than 24h resulted in significant decrease of viability, abolishing all further attempts of cell culture.
Several research groups have demonstrated the option of short term storage of stem cells and other cell types at room temperature (subnormothermic) conditions [20, 30, 31] . In this study, we could confirm storage of the cells for up to 3 days preserving cell number, viability and cellular properties. Therefore we conclude it is convenient to use this short-term storage condition (+20°C) e.g. for transport purposes or for short term storage prior analysis in hospitals and diagnostic laboratories.
As to hypothermic storage, different levels of success can be found in the literature, strongly depended on the cell type and composition of preservation media [19, 32, 33] . In summary, hypothermic storage of cells in suspension causes swelling of cells due to cold inactivation of membrane pumps, as well as activation of cellular stress pathways [28, 34] resulting in rapid depletion of cellular energy reserves and loss of stored material. For our studied cell type, hypothermic storage in culture medium without the addition of colloids, antioxidants, and sugars does not allow necessary preservation outcome during this period, which is most likely connected to damages caused by hypothermia.
Cryopreservation
Influence of cryoprotective medium. Cryopreservation of cells with 5%, 10%, or 15% DMSO did not result in significant difference from the positive control in terms of cell number and cell viability according to Trypan blue staining, however, flow cytometry analysis with 7AAD showed minor reduction in viability in samples frozen with 15% DMSO. Metabolic activity data via MTT test also showed no differences compared to positive control. However, cell adherence decreased with lowering of DMSO concentration to 5% as well as monolayer formation was observed not on the 2nd day, as with the other samples, but on the 3rd day (Table 2) .
While after cryopreservation with propanediol the cell number and viability were not significantly changed according to Trypan blue staining, analysis with 7AAD in flow cytometry showed a decrease of viability. Here, MTT test showed an increase of activity, while at the same time adherence decreased to 65.8%±7.6 and monolayer was formed on the 3rd day.
Although after cryopreservation with sucrose the cell number remained unchanged, their viability dropped significantly to 58.4%±3.6, according to Trypan blue and 65.7%±5.8 of cells were positively stained for 7AAD. The level of MTT was reduced almost two fold as well as adherence, while monolayer was formed late at day 5.
Cryopreservation with ethylene glycol resulted in decrease of the cell number with preservation of viability, accompanied by increasing levels of MTT. However, only 66.5%±5.4 of cells adhered and monolayer was formed on the 3rd day.
Application of glycerol as a CPA did not result in decrease of the cell number and allowed preserving the viability. The level of MTT was lowered, but only 42.5%±3.8 of cells adhered and monolayer was formed on the 4th day.
Cryopreservation of samples in culture medium without the addition of serum did not result in any significant differences in comparison to the samples containing serum in all of the studied parameters. When preserved with 100% serum, the number of cells and their viability reduced; 81.5%±5.6 were capable to adhere; and the cells formed a monolayer 24h later (Table 3) . Experiments on replacement of culture medium with crystalloid solutions accepted for clinical applications, revealed the optimal results with Ringer's and Hank's solutions, which are the most physiologically balanced in salt content and pH (Table 3) . Their application resulted in 30% reduction of the cell number and about 20-30% decrease of viability, depending on the method of analysis. Interestingly, the cellular adhesion capability remained at quite high level allowing monolayer formation on day 3. However, cryopreservation in medium containing only 0.9% sodium chloride with 10% DMSO led to decrease of cell number to roughly 50%, the viability decreased to 42-75% and a monolayer was formed late at day 6. Attempts to replace the cryopreservation medium with 6% dextran or 6% polyvinylpyrrolidone (PVP) without adding DMSO resulted in significant decrease of the cell number, but remained cells retain viability and adhesive properties and formed a monolayer at day 3-4. After application of 6% Sorbitol or 6% HES the number of cells was reduced by more than two fold, adhesive properties were drastically reduced and monolayer was formed only on 8-10th day.
Negative controls were frozen in complete culture medium without addition of CPAs, while certain other samples were frozen in pharmacopoeia solutions where pH level, osmolality, ionic, vitamin and amino acid composition may differ from such parameters of the cell culture medium. This could explain a slightly higher cell count in negative controls after cryopreservation in comparison to the samples frozen without complete cell culture medium (Table 3) .
In this study, our results displayed that DMSO, propanediol and ethylene glycol were the most effective among studied CPAs for the placental MSCs. Interestingly, as to the other components of the medium, additional serum appeared to be not necessary for cryopreservation outcome within the studied parameters; the highest survival of cells could be observed in serum-free standard culture medium containing CPAs. Furthermore, it is possible to replace the culture medium with Ringer's or Hank's solution with a slight decrease in the cell number and viability parameters after cryopreservation, which become significantly reduced in case of replacing the culture medium with sodium chloride physiological solution. Such results indicate possibilities for the future towards development of serum-and xeno-free cryopreservation techniques currently investigated by other research groups [35, 36] complying with latest GMP standards. Besides, we demonstrate the new possibility to use dextran or polyvinylpyrrolidone in cryopreservation solutions, which also possess cryoprotective effects, but cause the reduction of cell number and viability by 20-30%. Application of sorbitol or HES drastically reduces these parameters and is inconvenient. Other groups were able to show efficiency of HES only in combination with other CPAs, but not the HES alone [37] . Influence of cooling rates. One of the key parameters influencing the outcome of cryopreservation is the cooling rate [23] . In general, freezing protocols for MSCs seem to be reasonably established [24] , but it is still necessary to analyze other options, which might be convenient from the practical and economic perspectives for a particular cell type. Placental MSC number decreased only slightly, to 5.3 x 10 5 after cooling by direct immersion into liquid nitrogen. However, only 2.3-9% of these cells still possessed viability, values of MTT test or resazurin reduction were below detection limits and only few single cells adhered to plastic (Fig  4) . Thus, formation of a monolayer was not observed (Table 4) . Slow cooling to -20°C decreased cell number and viability to about 50% of the cells initially frozen. Whereas measurable data of resazurin reduction and MTT test were obtained, only single cells were capable to adhere (Fig 4) and were not sufficient to form a monolayer (Table 4) .
Cooling down to -30°C allowed survival of significantly larger number of cells: about 60%, with 70-80% of them being viable. Functional tests were positive, about 20% of cells adhered to plastic (Fig 4) and formed a monolayer on the 6th day in culture (Table 4) .
Pronounced increase in MTT reaction alongside the decrease of resazurin reduction may be explained by necrotic and apoptotic changes in the cells after thawing [38] in the first hours, Cooling down to the range between -40°C and -80°C allowed to preserve cell number along with parameters of viability, functional tests and time required for the formation of monolayer without significant differences between the samples. An observed decrease of cell number and their functional characteristics at -40°C was not statistically significant.
In summary, our study demonstrates -40°C to -50°C as the minimum required end temperature to which placental MSC samples should be slowly cooled for short term cryopreservation, preferably transferred into liquid nitrogen for long term storage. Besides, from economical point of view, such parameters allow application of refrigeration equipment which is about 10 times less expensive in cost of acquisition and energy than the -80°C refrigerators and thus, could be available in a wider range of medical institutions and blood transfusion centers. Furthermore, establishment of -40/50°C storage protocols might lead to disposal of expensive programmable freezer technology and exclusion of costs for liquid nitrogen, if long term storage is not necessary. 
Conclusions
Short-term storage of placental MSCs at subnormothermic condition ensured the preservation of cell number, viability and cultural properties within 48 hours whereas further increase of the storage period at this temperature led to significant loss of both cell number and viability. The maximum period of storage at this temperature with possibility of cellular recovery and a monolayer formation was 72 hours.
Hypothermic storage at +4°C in cell culture medium without additional modifications led to reduction of the cell number and compromised cultural properties within 24 hours without chances of recovery.
DMSO and propandiol were the optimal CPAs for cryopreservation of placental MSCs ensuring maximum cell viability and retention of metabolic and cultural properties. The key role belongs to the ionic composition and acid-base balance of the cryoprotective medium, while adding extra serum did not significantly affect the outcome of cryopreservation.
In order to comply with the GMP requirements it is possible to cryopreserve placental MSCs without the standard culture medium by maintaining ionic composition and application of dextran or polyvinylpyrrolidone, which are certified for clinical use. However, the cell number and cell viability decreased by 20-30% after such cryopreservation procedures.
For cryopreservation of placental MSCs under GMP requirements it was possible to exclude serum without viability alteration. Moreover, it is possible to replace the culture medium for the Ringer's or Hank's solution (HBSS), although accompanied with the loss of approximately 20% of cells and a slight decrease in cell viability.
The optimal cooling rate for cryopreservation of placental MSCs was 1°C/min down to -40°C, followed by immersion into liquid nitrogen. Increasing of this temperature led to significant loss in cell number and viability with the upper temperature limit preceding rapid cooling (immersion to LN) and allowing further culture recovery at -30°C. Interestingly, lowering the temperature to -80°C did not result in any significant alterations.
Re-freezing of placental MSCs directly after thawing in the same medium without recultivation led to 50% loss of the cell number and 20% decrease of viability.
In summary, the data obtained in this study indicates the necessity and perspectives of development of alternative cryopreservation protocols for clinical application of MSCs utilizing GMP approved components and certified equipment, available or affordable to modern hospitals.
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